Mustang Bio Announces Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI Insight – Nasdaq
Mustang Bio Announces Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI InsightNasdaqManuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, "Optimizing T cell potency has the potential to enhan… Continue reading
